Premier Biomedical (BIEI) stock price, revenue, and financials

Premier Biomedical market cap is $618.8 k, and annual revenue was $39.80 k in FY 2018

$618.8 K

BIEI Mkt cap, 27-Mar-2020

$3.5 K

Premier Biomedical Revenue Q3, 2019
Premier Biomedical Gross profit (Q3, 2019)1.8 K
Premier Biomedical Gross profit margin (Q3, 2019), %52.3%
Premier Biomedical Net income (Q3, 2019)-181.6 K
Premier Biomedical EBIT (Q3, 2019)-64.6 K
Premier Biomedical Cash, 30-Sept-2019117.2 K

Premier Biomedical Income Statement

Annual

USDFY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Revenue

39.8k39.8k

Cost of goods sold

25.4k113.7k

Gross profit

14.3k(73.9k)

Gross profit Margin, %

36%(186%)

Sales and marketing expense

2.9k

R&D expense

78.4k217.4k196.2k234.1k113.9k184.3k

General and administrative expense

35.9k3.0m223.4k133.3k191.4k196.7k189.3k

Operating expense total

117.3k3.2m419.6k367.4k305.2k1.3m618.9k

EBIT

(1.7m)(4.5m)(1.4m)(2.4m)(637.9k)(1.3m)(692.8k)

EBIT margin, %

(3244%)(1741%)

Interest expense

626.0400.4k41.6k198.9k817.4k2.5m294.0k

Pre tax profit

(1.7m)

Net Income

(1.7m)(4.9m)(1.4m)(2.6m)(1.8m)(3.8m)(398.9k)

Premier Biomedical Balance Sheet

Annual

USDFY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

40.3k15.8k102.6k35.4k22.4k83.7k86.8k

Accounts Receivable

171.5m312.03.1k

Prepaid Expenses

69.06.0k9.5k9.2k34.8k43.9k

Inventories

84.8k26.0k

Current Assets

40.4k21.8k115.5k66.5k33.9k203.6k159.8k

PP&E

3.0k3.7k5.1k3.6k5.1k5.5k5.2k

Total Assets

43.4k25.5k120.6k70.2k39.0k209.1k165.0k

Accounts Payable

88.6k122.3k147.5k188.3k220.7k346.8k264.4k

Short-term debt

12.0k109.0k30.0k

Current Liabilities

119.2k274.5k188.4k346.5k699.7k2.8m2.3m

Total Debt

12.0k109.0k30.0k

Total Liabilities

346.5k699.7k2.8m2.3m

Common Stock

124.0184.0218.0823.06.4k57.0

Preferred Stock

2.0k2.0k

Additional Paid-in Capital

1.7m6.5m8.1m10.5m11.9m13.4m14.6m

Retained Earnings

(1.8m)(6.8m)(8.2m)(10.8m)(12.6m)(16.3m)(16.7m)

Total Equity

(75.8k)(249.0k)(67.8k)(276.3k)(660.7k)(2.6m)(2.1m)

Debt to Equity Ratio

-0.2 x-0.4 x-0.1 x

Debt to Assets Ratio

0.3 x4.3 x0.4 x

Financial Leverage

-0.6 x-0.1 x-1.8 x-0.3 x-0.1 x-0.1 x-0.1 x

Quarterly

USDQ1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019

Cash

3.5k52.3k73.4k173.4k45.3k73.7k113.6k199.4k46.7k95.9k26.5k73.4k38.7k38.6k27.8k209.9k125.3k102.5k79.2k10.3k63.2k81.2k87.0k117.2k

Accounts Receivable

834.02.0k2.4k2.0k3.4k

Prepaid Expenses

563.0375.0187.0563.0375.0187.05.5k32.2k14.6k4.5k8.3k8.9k15.8k11.5k13.0k9.5k17.7k7.4k33.3k35.8k38.1k40.0k35.4k36.5k

Inventories

108.0k79.4k123.4k119.2k23.9k22.2k20.5k

Current Assets

4.0k52.7k73.6k174.0k45.6k73.9k119.1k231.7k61.4k107.5k39.1k86.8k54.4k50.1k40.9k219.4k266.9k218.8k192.0k169.5k222.4k147.5k146.7k177.6k

PP&E

2.3k2.9k2.7k3.9k3.5k3.2k3.0k4.7k4.4k4.0k6.7k6.2k5.6k4.6k6.6k5.9k6.9k6.3k5.8k7.3k8.7k7.9k

Total Assets

16.9k69.8k104.7k176.8k48.4k77.8k122.6k234.9k64.4k112.2k43.5k90.8k61.1k56.3k46.5k224.0k273.5k224.7k198.9k175.8k228.1k154.9k155.3k185.5k

Accounts Payable

13.6k23.4k30.4k161.9k93.8k99.0k17.8k42.8k34.6k209.5k237.9k299.4k83.4k143.7k210.1k178.4k163.1k350.1k346.9k347.6k307.0k268.1k224.7k192.5k

Short-term debt

12.0k12.0k12.0k12.0k9.0k30.0k30.0k30.0k30.0k30.0k30.0k

Current Liabilities

13.6k35.4k60.3k197.7k147.7k180.1k20.8k60.0k53.3k359.1k420.4k516.3k359.7k800.6k863.7k5.4m6.5m2.9m2.1m2.2m2.5m2.1m2.3m2.3m

Total Debt

12.0k12.0k12.0k12.0k9.0k30.0k30.0k30.0k30.0k30.0k30.0k

Total Liabilities

420.4k516.3k359.7k800.6k863.7k5.4m6.5m2.9m2.1m2.2m2.5m2.1m2.3m2.3m

Common Stock

115.0115.0123.0156.0156.0172.0196.0207.0208.0218.022.1m263.0952.01.3k1.9k4.9k5.2k4.9k7.5k30.038.085.0135.0492.0

Preferred Stock

2.0k2.0k2.0k2.0k2.0k2.0k2.0k2.0k2.0k

Additional Paid-in Capital

144.1k144.3k267.4k4.4m4.6m5.7m7.1m7.5m7.5m9.2m10.0m10.2m10.9m11.2m11.5m12.8m12.9m12.8m13.8m13.8m14.0m14.7m14.7m14.9m

Retained Earnings

(140.9k)(168.0k)(226.6k)(4.5m)(4.8m)(5.8m)(7.1m)(7.3m)(7.5m)(9.5m)(10.4m)(10.6m)(11.2m)(11.9m)(12.4m)(17.9m)(19.1m)(15.4m)(15.8m)(15.9m)(16.2m)(16.7m)(16.9m)(17.1m)

Total Equity

3.3k34.5k44.4k(20.8k)(99.4k)(102.3k)101.8k174.9k11.0k(246.9k)(377.0k)(425.5k)(298.5k)(744.4k)(817.2k)(5.1m)(6.2m)(2.7m)(1.9m)(2.0m)(2.2m)(2.0m)(2.1m)(2.1m)

Debt to Equity Ratio

0.3 x0.3 x-0.6 x-0.1 x-0.1 x-0.1 x0 x0 x0 x0 x0 x

Debt to Assets Ratio

0.2 x0.1 x0.1 x0.2 x0.1 x0.5 x0.5 x0.6 x0.1 x0.1 x0.1 x

Financial Leverage

5.1 x2 x2.4 x-8.5 x-0.5 x-0.8 x1.2 x1.3 x5.8 x-0.5 x-0.1 x-0.2 x-0.2 x-0.1 x-0.1 x0 x0 x-0.1 x-0.1 x-0.1 x-0.1 x-0.1 x-0.1 x-0.1 x

Premier Biomedical Cash Flow

Annual

USDFY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Net Income

(1.7m)(4.9m)(1.4m)(2.6m)(1.8m)(3.8m)(398.9k)

Depreciation and Amortization

201.0767.0954.01.5k2.1k2.3k2.3k

Accounts Receivable

312.02.8k

Inventories

84.8k28.9k

Accounts Payable

86.3k33.7k25.2k40.8k32.5k126.1k(82.4k)

Cash From Operating Activities

(126.6k)(428.2k)(639.1k)(462.2k)(483.6k)(509.4k)(444.9k)

Purchases of PP&E

3.2k(3.5k)(2.7k)(2.0k)

Cash From Investing Activities

(9.5k)(1.4k)(2.4k)(3.5k)(2.7k)(2.0k)

Short-term Borrowings

(30.0k)

Dividends Paid

(79.9k)

Cash From Financing Activities

150.2k405.1k728.3k395.0k474.2k573.4k450.0k

Net Change in Cash

14.0k(24.5k)86.8k(67.2k)(13.0k)61.3k3.1k

Interest Paid

20.8k32.6k13.5k5.6k369.0

Income Taxes Paid

Quarterly

USDQ1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019

Net Income

(26.9k)(54.0k)(112.6k)(2.6m)(2.8m)(3.9m)(307.3k)(517.1k)(764.2k)(1.3m)(2.2m)(2.4m)(415.1k)(1.1m)(1.6m)(5.3m)(6.6m)(2.9m)566.3k466.3k102.8k68.5k(158.5k)(340.2k)

Depreciation and Amortization

60.0162.0325.0534.0233.0466.0698.0407.0759.01.1k498.01.0k1.6k528.01.2k1.9k591.01.2k1.7k647.01.4k2.1k

Accounts Receivable

834.0(312.0)(312.0)1.7k709.01.1k(295.0)

Inventories

108.0k(5.4k)38.7k34.4k2.1k3.8k5.5k

Accounts Payable

4.7k12.2k28.1k73.3k5.2k10.4k(104.6k)(79.6k)(87.7k)62.0k90.4k152.0k(104.8k)(44.6k)21.8k(42.3k)(57.7k)129.3k42.0746.0(39.8k)3.7k(39.7k)(71.9k)

Cash From Operating Activities

(22.8k)(42.1k)(72.8k)(72.9k)(206.5k)(296.8k)(304.5k)(418.6k)(571.3k)(121.7k)(191.1k)(269.2k)(238.7k)(323.8k)(403.0k)(113.8k)(345.7k)(370.5k)(62.5k)(191.4k)(318.5k)(67.8k)(174.9k)(273.2k)

Purchases of PP&E

2.4k(2.7k)(2.7k)(2.0k)(2.0k)(2.0k)(2.8k)(4.8k)(4.8k)

Cash From Investing Activities

(2.0k)(8.7k)(1.4k)(3.5k)(3.5k)(3.5k)(2.1k)(4.8k)(2.7k)(2.0k)(2.0k)(2.0k)(2.8k)(4.8k)(4.8k)

Dividends Paid

(79.9k)(79.9k)

Cash From Financing Activities

70.1k128.7k206.0k211.5k331.6k402.3k602.3k602.3k115.0k115.0k240.0k245.5k330.5k399.0k303.3k453.3k453.3k60.0k120.0k300.0k65.0k180.0k308.4k

Net Change in Cash

(22.8k)26.0k47.2k133.1k5.0k33.4k97.8k183.6k30.9k(6.7k)(76.1k)(29.2k)3.3k3.2k(7.6k)187.4k102.9k80.1k(4.5k)(73.4k)(20.5k)(5.6k)216.030.4k

Interest Paid

3.5k32.6k32.6k32.6k13.5k13.5k13.5k629.0936.01.5k

Income Taxes Paid

Premier Biomedical Ratios

USDY, 2019

Financial Leverage

-0.1 x